Lead party: Pharma Capital S.A (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Afric-Phar Laboratories (private company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Morocco
Transaction type: Merger/Acquisition(M&A) · Asset class: Private Equity · Instrument: Equity · Equity stake: 0.9535%
Lead investor/buyer: Pharma Capital S.A · Investors/buyers: Pharma Capital S.A
Legal advisers: not identified in the source record.
Source: announced 11 November 2024. Original announcement: en.7news.ma.


